6533b837fe1ef96bd12a262a

RESEARCH PRODUCT

We-P11:264 Use of stents with sirolimus is significantly associated with a reduction in mortality and cardiovascular morbidity at 6- and 12-months post-PTCA

Maurizio AvernaL. CampoloManfredi RizzoF. ContornoG. BaroneA. FrasheriCarlo M. BarbagalloA. NotarbartoloSalvatore AmatoV. Pernice

subject

medicine.medical_specialtybusiness.industryInternal medicinemedicine.medical_treatmentSirolimusInternal MedicinemedicineCardiologyGeneral MedicineCardiology and Cardiovascular MedicinebusinessReduction (orthopedic surgery)medicine.drughttps://doi.org/10.1016/s1567-5688(06)81617-x